Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment

ABB India bags automation order for Reliance Life Sciences' biopharmaceutical facilities

ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra

Hikal receives Brazilian GMP certification and USFDA EIR for Bangalore and Panoli facilities

Honeywell, Recipharm to speed development of inhalers

Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs

SSI Strategy to acquires NDA Group partner to form global life sciences consultancy

Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base

Exor to buy 15% shareholding in Philips

Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases

Parexel and Partex collaborate to leverage on AI and Big Data to accelerate drug delivery

Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets

Lincoln Pharmaceuticals posts Q1 FY24 standalone net profit at Rs. 19.01 Cr

Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr

US FDA approval is in line with de-risking strategy for additional API site to service our global customer base

Surging demand for Korean pharma in 2023 ahead of CPHI Korea

Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings